A Comparison of Botulinum Toxin A and Intralesional Steroids for the Treatment of Plantar Fasciitis

Elizondo-Rodriguez, Jorge; Araujo-Lopez, Yariel; Moreno-González, Jorge; Cárdenas-Estrada, Eloy; O, Mendoza-Lemus; Acosta-Olivo, Carlos

doi:10.1177/1071100712460215

Cited by 58 publications

(59 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…(7) One study (18) reported better results in the botulinum toxin A injection group (intervention group) compared to the corticosteroid injection group. The remaining four studies (15,16,19,21) showed significant pain reduction in both intervention groups at follow-up intervals when compared to baseline but no significant differences between the intervention groups.…”

Section: Patient-assessed Outcome: Foot Painmentioning

confidence: 99%

“…The majority of studies investigated the use of palpation-guided corticosteroid injections, (7,15,16,(18)(19)(20)(21) while two studies (14,17) looked solely at US-guided corticosteroid injections. Only one study by Ball et al (13) included both palpation-and US-guided corticosteroid injections for comparison against a placebo; however, no significant differences in heel pain reduction between the US-and palpation-guided corticosteroid injection groups were found.…”

Section: Us-and Palpation-guided Corticosteroid Injectionsmentioning

confidence: 99%

“…Five RCTs explored the use of long-acting corticosteroids, i.e. dexamethasone (14,16,18) and betamethasone, (17,19) while the other five investigated the use of intermediate-acting corticosteroids, i.e. methylprednisolone, (13,15,21) prednisolone (7) and triamcinolone.…”

Section: Corticosteroid Injectionsmentioning

confidence: 99%

“…Some of these scales were not designed to assess patients with plantar fasciitis; for example, the Maryland Foot Score was designed to assess foot injuries, the American Orthopaedic Foot and Ankle Society's Ankle-Hindfoot Scale was designed to assess ankle and hindfoot joint injuries, while the Foot and Ankle Disability Index (FADI) is used to detect functional limitations in subjects with chronic ankle instability. However, all three scales were used in conjunction with VAS in the studies (16,18,21) concerned.…”

Section: Patient-assessed Outcome: Foot Painmentioning

confidence: 99%

“…methylprednisolone, (13,15,21) prednisolone (7) and triamcinolone. (20) To guide the corticosteroid injections, seven RCTs used the palpation method, (7,15,16,(18)(19)(20)(21) two used USguidance, (14,17) and one used both US-and palpation-guided injections in different arms. (13) Three approaches of injections were employed in the studies: eight RCTs adopted the medial approach, (7,(14)(15)(16)(17)(18)(19)(20) one adopted the posterior approach (13) and one involved injections through the plantar aspect of the heel pad.…”

Section: Corticosteroid Injectionsmentioning

confidence: 99%

See 4 more Smart Citations

The effectiveness of corticosteroid injection in the treatment of plantar fasciitis

Ang¹

2015

smedj

View full text Add to dashboard Cite

Plantar fasciitis is a common cause of heel pain in adults. Although it is usually a self-limiting condition, the pain may become prolonged and severe enough to cause significant distress and disruption to the patient's daily activities and work. PubMed and Cochrane Central Register of Controlled Trials databases were searched for randomised controlled trials (RCTs) and a total of ten RCTs were selected for evaluation. These RCTs involved the use of either palpation-or ultrasonography-guided corticosteroid injections in patients diagnosed with plantar fasciitis. All placebo-controlled RCTs showed a significant reduction in pain with the use of corticosteroid injections. Some studies also showed that corticosteroid injections yielded better results than other treatment modalities. However, it is evident from these studies that the effects of corticosteroid injections are usually short-term, lasting 4-12 weeks in duration. Complications such as plantar fascia rupture are uncommon, but physicians need to weigh the treatment benefits against such risks.

show abstract

Section: Patient-assessed Outcome: Foot Painmentioning

confidence: 99%

Section: Us-and Palpation-guided Corticosteroid Injectionsmentioning

confidence: 99%

Section: Corticosteroid Injectionsmentioning

confidence: 99%

Section: Patient-assessed Outcome: Foot Painmentioning

confidence: 99%

Section: Corticosteroid Injectionsmentioning

confidence: 99%

See 3 more Smart Citations

The effectiveness of corticosteroid injection in the treatment of plantar fasciitis

Ang¹

2015

smedj

View full text Add to dashboard Cite

show abstract

Injected corticosteroids for treating plantar heel pain in adults

David

Sankarapandian

Christopher

et al. 2017

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

show abstract

Comparison of efficacy of eight treatments for plantar fasciitis: A network meta‐analysis

Lin

2018

Journal Cellular Physiology

View full text Add to dashboard Cite

The objective of this network meta-analysis (NMA) was to assess the pain relief performance of eight different plantar fasciitis therapies, including nonsteroidal anti-inflammatory medications, corticosteroid injections (CSs), autologous whole blood, platelet-rich plasma (PRP), extracorporeal shockwave therapy (ESWT), ultrasound therapy (US), botulinum toxin A (BTX-A), and dry needling (DN). Published prospective or randomized controlled trials (RCTs) as for the above eight therapies were identified by searching CNKI, PubMed, and Embase. Mean difference (MD) and 95% credible intervals (CrIs) of visual analogue scale (VAS) were used to evaluate multiaspect comparisons. The ranking result was obtained by utilizing surface under cumulative ranking curve (SUCRA). Node-splitting plots were conducted to assess the consistency between direct and indirect evidence. Egger's test and funnel plots were performed to examine publication bias. Forty-one trials with a total of 2,889 cases were involved in this NMA. In terms of 1-month VAS, only ESWT turned out to be of better efficacy than placebo (MD = -3.3; CrI: [-5.3, -1.1]). No statistically significant difference was found between pair-wise comparisons concerning 2-month VAS. ESWT also demonstrated better efficacy as for 3-month results (MD = -2.7; CrI: [-4.2, -1.3]). Besides, CSs was significantly better than placebo as well in 3-month results (MD = -2.1; CrI: [-4.1, -0.19]). With regard to 6-month VAS results, ESWT performed better than placebo (MD = -3.0; CrI: [-5.0, -0.51]). According to the SUCRA, ESWT ranked the first as for all seven outcomes. ESWT might be the optimal treatment. In addition, BTX-A and PRP were considered as suboptimal.

show abstract

A Comparison of Botulinum Toxin A and Intralesional Steroids for the Treatment of Plantar Fasciitis

Abstract: Level I, therapeutic studies.

Cited by 58 publications

References 31 publications

The effectiveness of corticosteroid injection in the treatment of plantar fasciitis

The effectiveness of corticosteroid injection in the treatment of plantar fasciitis

Injected corticosteroids for treating plantar heel pain in adults

Comparison of efficacy of eight treatments for plantar fasciitis: A network meta‐analysis

Contact Info

Product

Resources

About